StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Zenas BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Zenas BioPharma's price to book ratio was 7.4× on Nov 11, 2026, against 8.3× a year earlier. Over the last 2 years it ranged from 0.9× to 8.3×, with a median of 3.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.4×−0.4
2025Dec 31, 20257.8×+6.9
2024Dec 31, 20241.0×–

More Zenas BioPharma figures

See a number that looks wrong?